1020 Discovery Road #100
191 articles with Prime Therapeutics
Prime Therapeutics launches MedDrive™, a first-of-its kind medical drug management program uniquely aligned with its Blue Plan clients
MedDrive to tackle the toughest challenges facing growing medical Rx drug spend, harness the multi-billion-dollar potential savings in biosimilar market
Prime Therapeutics proactive prescriber outreach significantly improves statin use in Medicare members with diabetes
Using a proactive prescriber outreach program, Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving nearly 33 million members nationally, saw increased statin use in Medicare members with diabetes
Prime Therapeutics LLC's President and CEO Ken Paulus is joining over 2,000 other chief executive officers by signing the CEO Action for Diversity & Inclusion pledge.
Prime Therapeutics applauds new legislation to drive greater biosimilar uptake, lower total cost of care
Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) serving approximately 33 million members nationally, released the following statement in response to the recent enactment of " The Ensuring Innovation Act" and the " Advancing Education on Biosimilars Act of 2021 " by the U.S. Congress.
Prime Therapeutics' study shows total cost of care for CAR-T plus post-treatment events can exceed $1 million
Blue Cross and Blue Shield plans can better forecast and manage the total cost of chimeric antigen receptor T-cell (CAR-T) therapies for members with relapsed or refractory B-cell lymphoma by putting Prime Therapeutics LLC (Prime) insights into action.
Prime Therapeutics LLC recently learned of a privacy incident that affected a subset of its covered members.
Prime Therapeutics' predictive model expands efforts to reduce potential misuse and abuse of opioids
In an effort to help identify both new and prior users of opioids who may be at risk for opioid use harm and to ultimately help prevent misuse, Prime Therapeutics LLC (Prime) is expanding its predictive models beyond Medicare, to now
Prime Therapeutics and Takeda agree to outcomes-based arrangement for Hemophilia A treatment ADVATE® [Antihemophilic Factor (Recombinant)]
In an effort to help assess the value of hemophilia A treatments relative to total health care costs and emergency department visits, Prime Therapeutics LLC (Prime) has finalized an arrangement with Takeda Pharmaceutica
Prime Therapeutics welcomes three leaders to transform the PBM's technology, data analytics solutions
Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving more than 30 million members nationally, recently welcomed three new leaders to transform its information technology and data management and analytics areas.
Blue Cross and Blue Shield of Nebraska, Prime Therapeutics provide free over-the-counter medicines, products to Medicare Advantage members
Quarterly, prepaid cards aim to make it easier, more affordable for seniors to make better health choices, stay safe during COVID-19
MedSelect leverages Prime's novel medical drug management strategy to drive appropriate use of medical benefit drugs, cost effectiveness and better health outcomes
Lower total cost of care, hospitalizations, emergency visits associated with greater drug adherence among Medicare Advantage members
Prime Therapeutics researchers studied hypertension, cholesterol and diabetes medications
Annual drug costs increased $1.25 billion for members with more than $250,000 in annual drug spend - doubling in four years
Rare disease therapy. One-time gene therapies. High-priced cancer drugs. These are all reasons why a consumer may have drug costs of $250,000 or more annually.
Prime Therapeutics Adds Rx Savings Solutions Tool to Bring Visibility to Prescription Drug Prices, Aims to Improve Consumer Experience
Prime Therapeutics LLC's (Prime) now offers its Blue Plan clients and their 30 million members a new tool, Rx Savings Solutions.
Prime Therapeutics and RxRevu Deploy Real Time Benefit Check Solution to Improve Prescription Price Transparency for Members
Prime Therapeutics LLC (Prime) and RxRevu , the nation's leading prescription price transparency company, are teaming up to offer Real Time Benefit Check, aka Real-Time Prescription Benefit, aiming to improve members' health while
Prime Therapeutics LLC (Prime) is rolling out Real Time Benefit Check starting with myBenefitCheck from health care technology pioneer DrFirst, giving health care providers comprehensive information so they can easily prescribe the most appropriate and cost-effective medications at the point of care.
Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) serving more than 30 million members nationally, signed a value-based agreement with EMD Serono for its oral multiple sclerosis (MS) therapy, MAVENCLAD ® (c
Kyle Skiermont to join Prime Therapeutics as senior vice president, specialty pharmacy and home delivery services
Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving more than 30 million members nationally, has named Kyle Skiermont, PharmD, as senior vice president, specialty pharmacy and home delivery services.
Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving 30 million people, evaluated its integrated medical and pharmacy claims data to identify those members new to preventive therapy for hereditary angioedema (HAE).
A program by pharmacy benefit manager Prime Therapeutics LLC, in which a managed care pharmacist reviewed members' drug therapies including a number of high-cost specialty medications, saved a net $2.4 million in health care costs in one year.